The POTS Diagnosis Isn't Just a Medical Problem — It's a Franchise Problem

There is a version of this Warriors season where Kristaps Porzingis becomes the piece that finally makes Golden State dangerous again in the frontcourt. That version is gone. What replaced it, before a single meaningful game was played, is an indefinite absence with no clear resolution — and a medical situation that, by its very nature, resists the kind of "he'll be back in six weeks" reassurance that front offices can plan around.

POTS — postural orthostatic tachycardia syndrome — is not a torn ligament with a standard recovery arc. Porzingis was first diagnosed with the condition in 2025, and the fact that it is now described as recurring tells you something important: this is not a problem Golden State solved. It came back. And when a cardiovascular autonomic disorder comes back in an athlete whose entire value proposition is built on his size and his ability to stay on the floor, the Warriors are not dealing with an injury timeline. They are dealing with a question mark that may not have an answer this season.

The history of teams that have built around Porzingis is not encouraging. In Dallas, in Boston, the pattern repeated itself — enormous promise, genuine impact when healthy, and then the floor falling out. Golden State, to its credit, presumably went in with eyes open. But knowing a risk exists and then absorbing it in real time, on opening night, with Charles Bassey also ruled out for the opener and the team already exploring trade options, are two different things. The Warriors reportedly entered the trade market almost immediately, which tells you the front office under Mike Dunleavy understands they cannot simply wait this out.

What makes this genuinely structural rather than merely unfortunate is the timing relative to the rest of the roster. Steph Curry tweaked his ankle in practice and had people holding their breath for days before Steve Kerr cleared him. Brandin Podziemski — who just signed a lucrative extension and is supposed to be part of the young core growing into something real — missed the opener with back soreness. Draymond Green is still here, still wants to retire a Warrior, but has already acknowledged publicly that he'll play out his current deal and that his future beyond it is genuinely uncertain. The connective tissue of this team is fraying at multiple points simultaneously.

My read is this: the Porzingis situation forces Golden State into a decision it wasn't supposed to face yet. Either you find a trade that brings back a functional, available big — accepting that the return on a player with recurring POTS will be painful — or you ask a roster that was already thin in the frontcourt to absorb a full season without its most important post presence. Neither path is clean. But franchises that have tried to simply "play through" a major center absence without addressing it — think of the years Cleveland tried to paper over its frontcourt deficiencies in the post-championship hangover, or Houston's repeated attempts to build around an injured big — have almost universally lost the season in slow motion. The Warriors have enough star power to stay relevant. They do not have enough frontcourt depth to pretend the problem isn't there.

Curry reflected publicly on what Porzingis' absence means for the team, which is notable. He didn't have to say anything. The fact that he did suggests even the franchise's anchor understands the weight of this moment. Rookie Yaxel Lendeborg has apparently impressed GM Dunleavy enough to generate genuine buzz, and that matters — but asking a rookie to fill a void this large, this early, is a significant ask. Golden State's front office built something here with real potential. The Porzingis diagnosis, recurring and unresolved, is the single biggest threat to whether any of that potential gets realized in 2026-27.